中华急诊医学杂志
中華急診醫學雜誌
중화급진의학잡지
CHINESE JOURNAL OF EMERGENCY MEDICINE
2011年
7期
742-745
,共4页
袁志%沈华浩%张根生%应英华
袁誌%瀋華浩%張根生%應英華
원지%침화호%장근생%응영화
慢性阻塞性%肺疾病呼吸衰竭%早期乳酸清除率%预后
慢性阻塞性%肺疾病呼吸衰竭%早期乳痠清除率%預後
만성조새성%폐질병호흡쇠갈%조기유산청제솔%예후
Chronic obstructive pulmonary disease%Respiratory failure%Early lactate clearance rate%Prognosis
目的 探讨早期乳酸清除率对重症慢性阻塞性肺疾病(COPD)患者的临床意义.方法 选取COPD合并呼吸衰竭住院患者108例进行前瞻性观察研究,根据患者病情转归分为存活组82例、死亡组26例;存活组中根据是否行有创机械通气治疗再分为常规治疗组55例、有创机械通气组27例.测定患者治疗前与治疗6 h后的动脉血乳酸、动脉血气、急性生理与慢性健康状况(APACHE)Ⅱ评分及早期(6 h)乳酸清除率.同时以早期乳酸清除率10%为临界值分为高、低乳酸清除率两组,分析早期乳酸清除率与预后的关系.结果 治疗前有创机械通气组与死亡组比较,动脉血乳酸、pH值、PaCO2、PaO2、APACHEⅡ、氧合指数等差异均无统计学意义.治疗6 h后常规治疗组、有创机械通气组分别与死亡组比较,早期乳酸清除率有统计学意义(P<0.01),APACHEⅡ评分、pH值差异均无统计学意义.存活病例两组比较,治疗6 h后各项指标包括早期乳酸清除率差异均无统计学意义(P>0.05).三组治疗前、后自身对比中每组APACHEⅡ评分均无统计学意义.高乳酸清除率组病死率4.2%,显著低于低乳酸清除率组62.2%,差异有统计学意义(P<0.01).结论 早期乳酸清除率可作为评估重症COPD患者病情严重程度、初始治疗效果和预后的指标之一.
目的 探討早期乳痠清除率對重癥慢性阻塞性肺疾病(COPD)患者的臨床意義.方法 選取COPD閤併呼吸衰竭住院患者108例進行前瞻性觀察研究,根據患者病情轉歸分為存活組82例、死亡組26例;存活組中根據是否行有創機械通氣治療再分為常規治療組55例、有創機械通氣組27例.測定患者治療前與治療6 h後的動脈血乳痠、動脈血氣、急性生理與慢性健康狀況(APACHE)Ⅱ評分及早期(6 h)乳痠清除率.同時以早期乳痠清除率10%為臨界值分為高、低乳痠清除率兩組,分析早期乳痠清除率與預後的關繫.結果 治療前有創機械通氣組與死亡組比較,動脈血乳痠、pH值、PaCO2、PaO2、APACHEⅡ、氧閤指數等差異均無統計學意義.治療6 h後常規治療組、有創機械通氣組分彆與死亡組比較,早期乳痠清除率有統計學意義(P<0.01),APACHEⅡ評分、pH值差異均無統計學意義.存活病例兩組比較,治療6 h後各項指標包括早期乳痠清除率差異均無統計學意義(P>0.05).三組治療前、後自身對比中每組APACHEⅡ評分均無統計學意義.高乳痠清除率組病死率4.2%,顯著低于低乳痠清除率組62.2%,差異有統計學意義(P<0.01).結論 早期乳痠清除率可作為評估重癥COPD患者病情嚴重程度、初始治療效果和預後的指標之一.
목적 탐토조기유산청제솔대중증만성조새성폐질병(COPD)환자적림상의의.방법 선취COPD합병호흡쇠갈주원환자108례진행전첨성관찰연구,근거환자병정전귀분위존활조82례、사망조26례;존활조중근거시부행유창궤계통기치료재분위상규치료조55례、유창궤계통기조27례.측정환자치료전여치료6 h후적동맥혈유산、동맥혈기、급성생리여만성건강상황(APACHE)Ⅱ평분급조기(6 h)유산청제솔.동시이조기유산청제솔10%위림계치분위고、저유산청제솔량조,분석조기유산청제솔여예후적관계.결과 치료전유창궤계통기조여사망조비교,동맥혈유산、pH치、PaCO2、PaO2、APACHEⅡ、양합지수등차이균무통계학의의.치료6 h후상규치료조、유창궤계통기조분별여사망조비교,조기유산청제솔유통계학의의(P<0.01),APACHEⅡ평분、pH치차이균무통계학의의.존활병례량조비교,치료6 h후각항지표포괄조기유산청제솔차이균무통계학의의(P>0.05).삼조치료전、후자신대비중매조APACHEⅡ평분균무통계학의의.고유산청제솔조병사솔4.2%,현저저우저유산청제솔조62.2%,차이유통계학의의(P<0.01).결론 조기유산청제솔가작위평고중증COPD환자병정엄중정도、초시치료효과화예후적지표지일.
Objective To investigate the clinical significance of early lactate clearance rate in respect of the prognosis of patients with severe chronic obstructive pulmonary disease (COPD) . Methods A total of 108 COPD patients with respiratory failure were studied prospectively. The patients were divided into survival group ( n = 82) and the death group ( n = 26) , and the survival group further divided into the conventional treatment subgroup ( n = 55 ) and the invasive ventilation subgroup ( n = 27 ) . Arterial blood lactate, arterial gas analysis, APACHE Ⅱ score and the 6-hour clearance rate were measured before and 6 hours after treatment in 3 groups. The high lactate clearance rate group (n =71 ) was defined as a lactate clearance rate > 10% , and the low lactate clearance rate group (n = 37) with a lactate clearance rate < 10%. The correlation between 6-hour lactate clearance rate and prognosis in patients was analyzed. Results Compared the survival patients in invasive ventilation group with the death group, there were no statistical differences in arterial blood lactate, pH value, PaCO2, PaO2, oxygenation index and APACHE Ⅱ score before the treatment. The 6-hour lactate clearance rate in survival patients in conventional treatment group or invasive ventilation group was significantly higher than that in the death group (t =31.2, P<0. 01; t =34.6, P<0. 01, respectively), while there were no statistical differences in APACHE Ⅱ score and pH value between these 3 groups. Between the conventional ventilation treatment group and the invasive ventilation treatment group, there was no statistical difference in 6-hour lactate clearance rate ( P > 0. 05 ) . There was no statistical difference in APACHE Ⅱ score between before treatment and after treatment in 3 groups. Mortality in high lactate clearance rate group (4. 2% ) was significantly lower than that in low lactate clearance rate group (62. 2% ) (x2 = 121.9, P < 0. 01 ) .Conclusions The early (6h) lactate clearance rate could be used as a marker for evaluating the severity,therapeutic efficacy and prognosis of patients with severe COPD.